SCHEMBL5953966

SCHEMBL5953966

CN1CCN(c2nccc(Oc3cccc4ccn(C)c34)n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.42
▸ HRH4 Q9H3N8 2/20 0.41
▸ HTR3A P46098 1/20 0.41
▸ JAK2 O60674 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PTK2 Q05397 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5954407 0.87 ACHE (0.46) ACHEALDH1A1
SCHEMBL5954538 0.81 CHKA (0.38) USP2PTK2
SCHEMBL4047440 0.79 MAP3K7 (0.39) ACHEJAK2JAK3ALDH1A1PTK2
SCHEMBL5954527 0.77 IKBKB (0.46) HRH4PTK2CCNA2CDK2
SCHEMBL28019839 0.73 OGA (0.51) ACHEHRH4HTR3AUSP2ALDH1A1
SCHEMBL30230144 0.73 OGA (0.51) ACHEHRH4HTR3AUSP2ALDH1A1
SCHEMBL5954597 0.72 HTR7 (0.35) —
SCHEMBL5953991 0.71 CYP2D6 (0.39) CYP2D6CDK2
SCHEMBL20075911 0.71 CA12 (0.49) ACHEHRH4HTR3ACCNT1CCNA2
SCHEMBL5125191 0.70 ACHE (0.43) ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235017-A1 Cytokine Inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-10-19 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235017-A1 Cytokine Inhibitors IL1B, IL1A, IL1R1 ACHE 3354/4885HRH4 350/4885HTR3A 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback